UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023232 |
|---|---|
| Receipt number | R000026771 |
| Scientific Title | The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA. |
| Date of disclosure of the study information | 2016/07/20 |
| Last modified on | 2016/07/19 17:26:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA.
Acronym
The characteristics of Japanese SCCmec type II and type IV MRSA
Scientific Title
The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA.
Scientific Title:Acronym
The characteristics of Japanese SCCmec type II and type IV MRSA
Region
| Japan |
Condition
Condition
MRSA infection
Classification by specialty
| Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare the clinical features and pathogenic genes (superantigens) between SCCmec type II and type IV MRSA in Japan and reveal the characteristic of SCCmec type II and IV MRSA.
Basic objectives2
Others
Basic objectives -Others
the comparsion between Japanese SCCmec type II and type IV MRSA
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
the clinical differences between SCCmec type II and type IV MRSA infection
Key secondary outcomes
1.patients' characteristics(age, sex, comorbidity, community-associated/health care-associated)
2.antimicrobial susceptibility
3.distribution of patogenic genes (sea,seb,sem,seo,tst)
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 0 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
patients from whom SCCmec type II or type IV MRSA was isolated between December 2014 and October 2015(only from skin and soft tissue or lower respiratpry tract specimens)
Key exclusion criteria
patients who were treated at the neonatal intensive care unit or growing care unit
Target sample size
280
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Norihiro Furusyo |
Organization
Kyusyu University Hospital
Division name
Department of General Internal Medicine
Zip code
Address
3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
TEL
092-642-5909
furusyo@gim.med.kyushu-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Fujiko Mitsumoto-Kaseida |
Organization
Kyushu University Hospital
Division name
Department of General Internal Medicine
Zip code
Address
3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
TEL
092-642-5909
Homepage URL
mitsu-f@gim.med.kyushu-u.ac.jp
Sponsor or person
Institute
Department of General Internal Medicine, Kyushu University Hospital
Institute
Department
Personal name
Funding Source
Organization
Department of General Internal Medicine, Kyushu University Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
YES
Study ID_1
27-134
Org. issuing International ID_1
Kyushu University ethics committee
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 07 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 08 | Month | 12 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 08 | Month | 12 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Japanese SCCmec type IV MRSA strains have been spread widely. Pathogenic gene combination patterns was dignificantly different between SCCmec type II and type IV MRSA.
Management information
Registered date
| 2016 | Year | 07 | Month | 19 | Day |
Last modified on
| 2016 | Year | 07 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026771
